Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China

Authors

Institutions

Publication Details

Journal
Expert Review of Vaccines
Published
2025-02-07
DOI
https://doi.org/10.1080/14760584.2025.2457463
Primary Topic
Herpesvirus Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China

Jinfang Sun, Hongxing Pan, Xianyun Chang, Fengcai Zhu et al.
Expert Review of Vaccines
Herpesvirus Infections and Treatments
article

Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China

Jinfang Sun, Hongxing Pan, Xianyun Chang, Fengcai Zhu, Jinhui Shi, Guifan Li, Yang Zhang, Hao Zhang, Shiyuan Wang, Jingxin Li
article en

Abstract

No abstract available for this paper.
Expert Review of VaccinesVol. 24(1)
Beijing VDJBio (China) (CN), Jiangsu Provincial Center for Disease Control and Prevention (CN)
Good health and well-being
Openalex Percentile: Top 96%
Herpesvirus Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.